drugset / Trial / NCT00821691

Action of Amantadine on Post-Stroke Aphasic Patients

NCT00821691 ↗

Phase 2/3 Completed 50 enrolled Centre Hospitalier Universitaire de Nice
RandomizedCrossoverDouble-blindTreatment

Summary

The objective of the study is to test the action of the amantadine, as DOPA-agonist, in a double blind cross-over trial, amantadine / placebo, on the verbal fluency of chronic post stroke aphasic patients.

Timeline

Start
2009-03
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amantadin Unknown 100 mg —

Indications